充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Lateral Wall Dysfunction Signals Onset of Progressive Heart Failure in Left Bundle Branch Block
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Lifestyle Modifications for Preventing and Treating Heart Failure
Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction

Clinical Trial

2018 Oct 22;17(1):137.

JOURNAL：Cardiovasc Diabetol.

Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Sardu C, Paolisso P, Sacra C et al.

8876

Keywords: cardiac resynchronization therapy with defibrillator; diabetes mellitus; arrhythmic burden; heart failure

FULL TEXT PDF